Wiskott-Aldrich syndrome: Long-term results of gene therapy developed

A single infusion of genetically corrected autologous hematopoietic stem cells can provide lasting clinical benefits for patients with Wiskott-Aldrich syndrome, a rare genetic disorder that impairs immune and platelet function, exposing affected children from an early age to severe infections, bleeding episodes, eczema and autoimmune complications.

Read it at Medical Xpress ↗

← Front page